Genmab — December 2019

[Helge_LarsenPI-redaktør]

Rigth now. Guest in our chat from Denmark, Sweden, Norway, Netherland, Belgium (David and friends), Finland, Jersey, Lithuania, Luxembourg, South Africa, US, GB and Switzerland.

[Bulder]

oh I love Swiss cheese

[Helge_LarsenPI-redaktør]

And now Spain and Hungary.

[transalp]

+24$ nu..

[bibob]

Ok Helge. So Denmark are the center in the World right now.

[E_L]

vd Winkel had toxicity as his main concern due to the high potency, so I am very
happy with this; i was a bit worried tbh...

[Bulder]

agree

[bibob]

Træls for dem som solgte i 1575.

[Bulder]

close in 24,01$ = 1622 dkk

[Bulder]

Let's see if the R&D update can add a little to this

[Helge_LarsenPI-redaktør]

Safety is important. Hope that potential partners can understand that the basics must be in order before dose scaling. Like when Plesner started in 2007 with daratumumab in almost homeopathic form.

[bibob]

Pensionisten. Det har Trump.

[Solsen]

Yes Helge - safety safety safety

[Mcjean]

They understand it Helge they not stupid in that sector. But exciting how high the go in dose scaling

[Helge_LarsenPI-redaktør]

bibob...Jeg chatter fra fabrikken i Kvanløse.

[Mcjean]

sammen med Trump?

[Helge_LarsenPI-redaktør]

[bibob]

Det må virkelig være en powerplant du har der Helge.

[Bulder]

Hvis maximal tolereret dosis ligger væsentligt over 12 mg må vi forvente bedre responser.

[Solsen]

Vi kunne godt have brugt en analyse over AE i dosisgrupperne